Tumor-agnostic precision medicine from the AACR GENIE database: clinical implications

MA Gouda, BE Nelson, L Buschhorn, A Wahida… - Clinical Cancer …, 2023 - AACR
Biomarker-driven cancer therapy has revolutionized precision oncology. With a better
understanding of tumor biology, tissue-agnostic targets have been characterized and …
被引用次数：29 相关文章

Tumor-Agnostic Precision Medicine from the AACR GENIE Database: Clinical Implications

MA Gouda, BE Nelson, L Buschhorn… - … : an official journal …, 2023 - pubmed.ncbi.nlm.nih.gov
Biomarker-driven cancer therapy has revolutionized precision oncology. With a better
understanding of tumor biology, tissue-agnostic targets have been characterized and …
[PDF] aacrjournals.org

[PDF][PDF] Tumor-Agnostic Precision Medicine from the AACR GENIE Database: Clinical Implications

MA Gouda, BE Nelson, L Buschhorn, A Wahida… - Clinical Cancer …, 2023 - AACR
Biomarker-driven cancer therapy has revolutionized precision oncology. With a better
understanding of tumor biology, tissue-agnostic targets have been characterized and …

Tumor-Agnostic Precision Medicine from the AACR GENIE Database: Clinical Implications

MA Gouda, BE Nelson… - Clinical Cancer …, 2023 - mdanderson.elsevierpure.com
Biomarker-driven cancer therapy has revolutionized precision oncology. With a better
understanding of tumor biology, tissueagnostic targets have been characterized and …
[HTML] nih.gov

[HTML][HTML] Tumor-Agnostic Precision Medicine from the AACR GENIE Database: Clinical Implications

MA Gouda, BE Nelson, L Buschhorn… - Clinical Cancer …, 2023 - ncbi.nlm.nih.gov
Biomarker-driven cancer therapy has revolutionized precision oncology. With a better
understanding of tumor biology, tissue-agnostic targets have been characterized and …